nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—BCHE—Triamcinolone—ankylosing spondylitis	0.0908	0.106	CbGbCtD
Irinotecan—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.0805	0.0941	CbGbCtD
Irinotecan—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0707	0.0827	CbGbCtD
Irinotecan—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0639	0.0747	CbGbCtD
Irinotecan—ABCC1—Methotrexate—ankylosing spondylitis	0.0383	0.0448	CbGbCtD
Irinotecan—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0354	0.0414	CbGbCtD
Irinotecan—ABCC2—Dexamethasone—ankylosing spondylitis	0.0353	0.0412	CbGbCtD
Irinotecan—ALB—Prednisone—ankylosing spondylitis	0.0352	0.0412	CbGbCtD
Irinotecan—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0323	0.0377	CbGbCtD
Irinotecan—ABCG2—Dexamethasone—ankylosing spondylitis	0.0319	0.0373	CbGbCtD
Irinotecan—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0304	0.0356	CbGbCtD
Irinotecan—ABCC2—Methotrexate—ankylosing spondylitis	0.0284	0.0331	CbGbCtD
Irinotecan—ABCG2—Methotrexate—ankylosing spondylitis	0.0256	0.03	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0236	0.0275	CbGbCtD
Irinotecan—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0236	0.0275	CbGbCtD
Irinotecan—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0224	0.0262	CbGbCtD
Irinotecan—ABCB1—Betamethasone—ankylosing spondylitis	0.0198	0.0231	CbGbCtD
Irinotecan—ABCB1—Prednisolone—ankylosing spondylitis	0.0195	0.0228	CbGbCtD
Irinotecan—ABCB1—Prednisone—ankylosing spondylitis	0.0184	0.0215	CbGbCtD
Irinotecan—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0182	0.0213	CbGbCtD
Irinotecan—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0177	0.0207	CbGbCtD
Irinotecan—ALB—Methotrexate—ankylosing spondylitis	0.0177	0.0207	CbGbCtD
Irinotecan—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0138	0.0161	CbGbCtD
Irinotecan—CYP3A4—Betamethasone—ankylosing spondylitis	0.0118	0.0139	CbGbCtD
Irinotecan—CYP3A4—Prednisolone—ankylosing spondylitis	0.0117	0.0137	CbGbCtD
Irinotecan—ABCB1—Dexamethasone—ankylosing spondylitis	0.0115	0.0134	CbGbCtD
Irinotecan—CYP3A4—Prednisone—ankylosing spondylitis	0.011	0.0129	CbGbCtD
Irinotecan—ABCB1—Methotrexate—ankylosing spondylitis	0.00924	0.0108	CbGbCtD
Irinotecan—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00689	0.00806	CbGbCtD
Irinotecan—Back pain—Triamcinolone—ankylosing spondylitis	0.000288	0.00199	CcSEcCtD
Irinotecan—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000284	0.00197	CcSEcCtD
Irinotecan—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000281	0.00194	CcSEcCtD
Irinotecan—Angiopathy—Betamethasone—ankylosing spondylitis	0.000281	0.00194	CcSEcCtD
Irinotecan—Hypertension—Prednisolone—ankylosing spondylitis	0.000279	0.00193	CcSEcCtD
Irinotecan—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000277	0.00191	CcSEcCtD
Irinotecan—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000277	0.00191	CcSEcCtD
Irinotecan—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000276	0.00191	CcSEcCtD
Irinotecan—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000276	0.00191	CcSEcCtD
Irinotecan—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000275	0.0019	CcSEcCtD
Irinotecan—Bradycardia—Prednisone—ankylosing spondylitis	0.000275	0.0019	CcSEcCtD
Irinotecan—Alopecia—Dexamethasone—ankylosing spondylitis	0.000274	0.00189	CcSEcCtD
Irinotecan—Alopecia—Betamethasone—ankylosing spondylitis	0.000274	0.00189	CcSEcCtD
Irinotecan—Discomfort—Prednisolone—ankylosing spondylitis	0.000272	0.00188	CcSEcCtD
Irinotecan—Haemoglobin—Prednisone—ankylosing spondylitis	0.000271	0.00188	CcSEcCtD
Irinotecan—Haemorrhage—Prednisone—ankylosing spondylitis	0.00027	0.00187	CcSEcCtD
Irinotecan—Malaise—Triamcinolone—ankylosing spondylitis	0.000268	0.00185	CcSEcCtD
Irinotecan—Malaise—Methylprednisolone—ankylosing spondylitis	0.000268	0.00185	CcSEcCtD
Irinotecan—Vertigo—Triamcinolone—ankylosing spondylitis	0.000267	0.00185	CcSEcCtD
Irinotecan—Syncope—Triamcinolone—ankylosing spondylitis	0.000267	0.00184	CcSEcCtD
Irinotecan—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000267	0.00184	CcSEcCtD
Irinotecan—Syncope—Methylprednisolone—ankylosing spondylitis	0.000266	0.00184	CcSEcCtD
Irinotecan—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000265	0.00183	CcSEcCtD
Irinotecan—Oedema—Prednisolone—ankylosing spondylitis	0.000264	0.00182	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000264	0.00182	CcSEcCtD
Irinotecan—Neutropenia—Methotrexate—ankylosing spondylitis	0.000264	0.00182	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000262	0.00181	CcSEcCtD
Irinotecan—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000261	0.00181	CcSEcCtD
Irinotecan—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000261	0.0018	CcSEcCtD
Irinotecan—Shock—Prednisolone—ankylosing spondylitis	0.00026	0.0018	CcSEcCtD
Irinotecan—Cough—Triamcinolone—ankylosing spondylitis	0.00026	0.00179	CcSEcCtD
Irinotecan—Hypertension—Triamcinolone—ankylosing spondylitis	0.000257	0.00178	CcSEcCtD
Irinotecan—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000256	0.00177	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000255	0.00176	CcSEcCtD
Irinotecan—Pneumonia—Methotrexate—ankylosing spondylitis	0.000253	0.00175	CcSEcCtD
Irinotecan—Flushing—Prednisone—ankylosing spondylitis	0.000251	0.00173	CcSEcCtD
Irinotecan—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00025	0.00173	CcSEcCtD
Irinotecan—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00025	0.00173	CcSEcCtD
Irinotecan—Discomfort—Triamcinolone—ankylosing spondylitis	0.00025	0.00173	CcSEcCtD
Irinotecan—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00025	0.00173	CcSEcCtD
Irinotecan—Renal failure—Methotrexate—ankylosing spondylitis	0.000247	0.00171	CcSEcCtD
Irinotecan—Stomatitis—Methotrexate—ankylosing spondylitis	0.000245	0.00169	CcSEcCtD
Irinotecan—Angiopathy—Prednisone—ankylosing spondylitis	0.000245	0.00169	CcSEcCtD
Irinotecan—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000244	0.00169	CcSEcCtD
Irinotecan—Immune system disorder—Prednisone—ankylosing spondylitis	0.000244	0.00169	CcSEcCtD
Irinotecan—Malaise—Dexamethasone—ankylosing spondylitis	0.000243	0.00168	CcSEcCtD
Irinotecan—Malaise—Betamethasone—ankylosing spondylitis	0.000243	0.00168	CcSEcCtD
Irinotecan—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000243	0.00168	CcSEcCtD
Irinotecan—Oedema—Triamcinolone—ankylosing spondylitis	0.000243	0.00168	CcSEcCtD
Irinotecan—Vertigo—Dexamethasone—ankylosing spondylitis	0.000242	0.00168	CcSEcCtD
Irinotecan—Vertigo—Betamethasone—ankylosing spondylitis	0.000242	0.00168	CcSEcCtD
Irinotecan—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000242	0.00167	CcSEcCtD
Irinotecan—Syncope—Dexamethasone—ankylosing spondylitis	0.000242	0.00167	CcSEcCtD
Irinotecan—Syncope—Betamethasone—ankylosing spondylitis	0.000242	0.00167	CcSEcCtD
Irinotecan—Arrhythmia—Prednisone—ankylosing spondylitis	0.000241	0.00167	CcSEcCtD
Irinotecan—Infection—Triamcinolone—ankylosing spondylitis	0.000241	0.00167	CcSEcCtD
Irinotecan—Sweating—Methotrexate—ankylosing spondylitis	0.000241	0.00167	CcSEcCtD
Irinotecan—Infection—Methylprednisolone—ankylosing spondylitis	0.000241	0.00166	CcSEcCtD
Irinotecan—Shock—Triamcinolone—ankylosing spondylitis	0.000239	0.00165	CcSEcCtD
Irinotecan—Insomnia—Prednisolone—ankylosing spondylitis	0.000239	0.00165	CcSEcCtD
Irinotecan—Alopecia—Prednisone—ankylosing spondylitis	0.000239	0.00165	CcSEcCtD
Irinotecan—Shock—Methylprednisolone—ankylosing spondylitis	0.000238	0.00165	CcSEcCtD
Irinotecan—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000238	0.00164	CcSEcCtD
Irinotecan—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000237	0.00164	CcSEcCtD
Irinotecan—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000237	0.00164	CcSEcCtD
Irinotecan—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000237	0.00164	CcSEcCtD
Irinotecan—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000235	0.00162	CcSEcCtD
Irinotecan—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000234	0.00162	CcSEcCtD
Irinotecan—Hypertension—Dexamethasone—ankylosing spondylitis	0.000233	0.00161	CcSEcCtD
Irinotecan—Hypertension—Betamethasone—ankylosing spondylitis	0.000233	0.00161	CcSEcCtD
Irinotecan—Discomfort—Dexamethasone—ankylosing spondylitis	0.000227	0.00157	CcSEcCtD
Irinotecan—Discomfort—Betamethasone—ankylosing spondylitis	0.000227	0.00157	CcSEcCtD
Irinotecan—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000227	0.00157	CcSEcCtD
Irinotecan—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000226	0.00156	CcSEcCtD
Irinotecan—Pain—Prednisolone—ankylosing spondylitis	0.000226	0.00156	CcSEcCtD
Irinotecan—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000226	0.00156	CcSEcCtD
Irinotecan—Oedema—Dexamethasone—ankylosing spondylitis	0.00022	0.00152	CcSEcCtD
Irinotecan—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00022	0.00152	CcSEcCtD
Irinotecan—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00022	0.00152	CcSEcCtD
Irinotecan—Oedema—Betamethasone—ankylosing spondylitis	0.00022	0.00152	CcSEcCtD
Irinotecan—Insomnia—Triamcinolone—ankylosing spondylitis	0.00022	0.00152	CcSEcCtD
Irinotecan—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000219	0.00151	CcSEcCtD
Irinotecan—Infection—Dexamethasone—ankylosing spondylitis	0.000219	0.00151	CcSEcCtD
Irinotecan—Infection—Betamethasone—ankylosing spondylitis	0.000219	0.00151	CcSEcCtD
Irinotecan—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000218	0.00151	CcSEcCtD
Irinotecan—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000218	0.00151	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000218	0.0015	CcSEcCtD
Irinotecan—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000217	0.0015	CcSEcCtD
Irinotecan—Visual impairment—Methotrexate—ankylosing spondylitis	0.000217	0.0015	CcSEcCtD
Irinotecan—Anaemia—Prednisone—ankylosing spondylitis	0.000217	0.0015	CcSEcCtD
Irinotecan—Shock—Dexamethasone—ankylosing spondylitis	0.000217	0.0015	CcSEcCtD
Irinotecan—Shock—Betamethasone—ankylosing spondylitis	0.000217	0.0015	CcSEcCtD
Irinotecan—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000216	0.0015	CcSEcCtD
Irinotecan—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000216	0.00149	CcSEcCtD
Irinotecan—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000216	0.00149	CcSEcCtD
Irinotecan—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000216	0.00149	CcSEcCtD
Irinotecan—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000216	0.00149	CcSEcCtD
Irinotecan—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000214	0.00148	CcSEcCtD
Irinotecan—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000213	0.00147	CcSEcCtD
Irinotecan—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000213	0.00147	CcSEcCtD
Irinotecan—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000213	0.00147	CcSEcCtD
Irinotecan—Malaise—Prednisone—ankylosing spondylitis	0.000212	0.00147	CcSEcCtD
Irinotecan—Vertigo—Prednisone—ankylosing spondylitis	0.000211	0.00146	CcSEcCtD
Irinotecan—Syncope—Prednisone—ankylosing spondylitis	0.000211	0.00146	CcSEcCtD
Irinotecan—Anorexia—Dexamethasone—ankylosing spondylitis	0.00021	0.00145	CcSEcCtD
Irinotecan—Anorexia—Betamethasone—ankylosing spondylitis	0.00021	0.00145	CcSEcCtD
Irinotecan—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000209	0.00145	CcSEcCtD
Irinotecan—Fatigue—Triamcinolone—ankylosing spondylitis	0.000209	0.00145	CcSEcCtD
Irinotecan—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000209	0.00144	CcSEcCtD
Irinotecan—Pain—Triamcinolone—ankylosing spondylitis	0.000208	0.00144	CcSEcCtD
Irinotecan—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000207	0.00143	CcSEcCtD
Irinotecan—Hypotension—Betamethasone—ankylosing spondylitis	0.000206	0.00142	CcSEcCtD
Irinotecan—Hypotension—Dexamethasone—ankylosing spondylitis	0.000206	0.00142	CcSEcCtD
Irinotecan—Angiopathy—Methotrexate—ankylosing spondylitis	0.000205	0.00142	CcSEcCtD
Irinotecan—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000204	0.00141	CcSEcCtD
Irinotecan—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000203	0.00141	CcSEcCtD
Irinotecan—Hypertension—Prednisone—ankylosing spondylitis	0.000203	0.0014	CcSEcCtD
Irinotecan—Chills—Methotrexate—ankylosing spondylitis	0.000202	0.0014	CcSEcCtD
Irinotecan—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.0002	0.00138	CcSEcCtD
Irinotecan—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0002	0.00138	CcSEcCtD
Irinotecan—Alopecia—Methotrexate—ankylosing spondylitis	0.000199	0.00138	CcSEcCtD
Irinotecan—Insomnia—Dexamethasone—ankylosing spondylitis	0.000199	0.00138	CcSEcCtD
Irinotecan—Insomnia—Betamethasone—ankylosing spondylitis	0.000199	0.00138	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000198	0.00137	CcSEcCtD
Irinotecan—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000198	0.00137	CcSEcCtD
Irinotecan—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000198	0.00137	CcSEcCtD
Irinotecan—Discomfort—Prednisone—ankylosing spondylitis	0.000198	0.00137	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000194	0.00134	CcSEcCtD
Irinotecan—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000194	0.00134	CcSEcCtD
Irinotecan—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000194	0.00134	CcSEcCtD
Irinotecan—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000192	0.00133	CcSEcCtD
Irinotecan—Oedema—Prednisone—ankylosing spondylitis	0.000192	0.00133	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000192	0.00133	CcSEcCtD
Irinotecan—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000191	0.00132	CcSEcCtD
Irinotecan—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000191	0.00132	CcSEcCtD
Irinotecan—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000191	0.00132	CcSEcCtD
Irinotecan—Infection—Prednisone—ankylosing spondylitis	0.000191	0.00132	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00019	0.00131	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00019	0.00131	CcSEcCtD
Irinotecan—Back pain—Methotrexate—ankylosing spondylitis	0.00019	0.00131	CcSEcCtD
Irinotecan—Fatigue—Betamethasone—ankylosing spondylitis	0.00019	0.00131	CcSEcCtD
Irinotecan—Fatigue—Dexamethasone—ankylosing spondylitis	0.00019	0.00131	CcSEcCtD
Irinotecan—Shock—Prednisone—ankylosing spondylitis	0.000189	0.0013	CcSEcCtD
Irinotecan—Pain—Dexamethasone—ankylosing spondylitis	0.000188	0.0013	CcSEcCtD
Irinotecan—Pain—Betamethasone—ankylosing spondylitis	0.000188	0.0013	CcSEcCtD
Irinotecan—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000188	0.0013	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000185	0.00128	CcSEcCtD
Irinotecan—Anorexia—Prednisone—ankylosing spondylitis	0.000183	0.00126	CcSEcCtD
Irinotecan—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000182	0.00126	CcSEcCtD
Irinotecan—Anaemia—Methotrexate—ankylosing spondylitis	0.000182	0.00126	CcSEcCtD
Irinotecan—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000181	0.00125	CcSEcCtD
Irinotecan—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000181	0.00125	CcSEcCtD
Irinotecan—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00018	0.00125	CcSEcCtD
Irinotecan—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00018	0.00125	CcSEcCtD
Irinotecan—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000179	0.00124	CcSEcCtD
Irinotecan—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000178	0.00123	CcSEcCtD
Irinotecan—Malaise—Methotrexate—ankylosing spondylitis	0.000177	0.00122	CcSEcCtD
Irinotecan—Vertigo—Methotrexate—ankylosing spondylitis	0.000176	0.00122	CcSEcCtD
Irinotecan—Leukopenia—Methotrexate—ankylosing spondylitis	0.000176	0.00122	CcSEcCtD
Irinotecan—Dizziness—Prednisolone—ankylosing spondylitis	0.000175	0.00121	CcSEcCtD
Irinotecan—Asthenia—Triamcinolone—ankylosing spondylitis	0.000174	0.0012	CcSEcCtD
Irinotecan—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000174	0.0012	CcSEcCtD
Irinotecan—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000174	0.0012	CcSEcCtD
Irinotecan—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000174	0.0012	CcSEcCtD
Irinotecan—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000174	0.0012	CcSEcCtD
Irinotecan—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000174	0.0012	CcSEcCtD
Irinotecan—Insomnia—Prednisone—ankylosing spondylitis	0.000173	0.0012	CcSEcCtD
Irinotecan—Paraesthesia—Prednisone—ankylosing spondylitis	0.000172	0.00119	CcSEcCtD
Irinotecan—Cough—Methotrexate—ankylosing spondylitis	0.000171	0.00118	CcSEcCtD
Irinotecan—Dyspepsia—Prednisone—ankylosing spondylitis	0.000169	0.00117	CcSEcCtD
Irinotecan—Decreased appetite—Prednisone—ankylosing spondylitis	0.000167	0.00115	CcSEcCtD
Irinotecan—Rash—Prednisolone—ankylosing spondylitis	0.000166	0.00115	CcSEcCtD
Irinotecan—Dermatitis—Prednisolone—ankylosing spondylitis	0.000166	0.00115	CcSEcCtD
Irinotecan—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000166	0.00115	CcSEcCtD
Irinotecan—Fatigue—Prednisone—ankylosing spondylitis	0.000165	0.00114	CcSEcCtD
Irinotecan—Headache—Prednisolone—ankylosing spondylitis	0.000165	0.00114	CcSEcCtD
Irinotecan—Discomfort—Methotrexate—ankylosing spondylitis	0.000165	0.00114	CcSEcCtD
Irinotecan—Constipation—Prednisone—ankylosing spondylitis	0.000164	0.00113	CcSEcCtD
Irinotecan—Confusional state—Methotrexate—ankylosing spondylitis	0.000162	0.00112	CcSEcCtD
Irinotecan—Dizziness—Triamcinolone—ankylosing spondylitis	0.000161	0.00111	CcSEcCtD
Irinotecan—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00016	0.00111	CcSEcCtD
Irinotecan—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00016	0.00111	CcSEcCtD
Irinotecan—Infection—Methotrexate—ankylosing spondylitis	0.000159	0.0011	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000158	0.00109	CcSEcCtD
Irinotecan—Asthenia—Dexamethasone—ankylosing spondylitis	0.000158	0.00109	CcSEcCtD
Irinotecan—Asthenia—Betamethasone—ankylosing spondylitis	0.000158	0.00109	CcSEcCtD
Irinotecan—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000157	0.00109	CcSEcCtD
Irinotecan—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000157	0.00109	CcSEcCtD
Irinotecan—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000157	0.00108	CcSEcCtD
Irinotecan—Nausea—Prednisolone—ankylosing spondylitis	0.000157	0.00108	CcSEcCtD
Irinotecan—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000155	0.00107	CcSEcCtD
Irinotecan—Vomiting—Triamcinolone—ankylosing spondylitis	0.000154	0.00107	CcSEcCtD
Irinotecan—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000154	0.00106	CcSEcCtD
Irinotecan—Rash—Triamcinolone—ankylosing spondylitis	0.000153	0.00106	CcSEcCtD
Irinotecan—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000153	0.00106	CcSEcCtD
Irinotecan—Anorexia—Methotrexate—ankylosing spondylitis	0.000153	0.00106	CcSEcCtD
Irinotecan—Rash—Methylprednisolone—ankylosing spondylitis	0.000153	0.00106	CcSEcCtD
Irinotecan—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000153	0.00105	CcSEcCtD
Irinotecan—Headache—Triamcinolone—ankylosing spondylitis	0.000152	0.00105	CcSEcCtD
Irinotecan—Headache—Methylprednisolone—ankylosing spondylitis	0.000152	0.00105	CcSEcCtD
Irinotecan—Abdominal pain—Prednisone—ankylosing spondylitis	0.000152	0.00105	CcSEcCtD
Irinotecan—Body temperature increased—Prednisone—ankylosing spondylitis	0.000152	0.00105	CcSEcCtD
Irinotecan—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000151	0.00104	CcSEcCtD
Irinotecan—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000151	0.00104	CcSEcCtD
Irinotecan—Hypotension—Methotrexate—ankylosing spondylitis	0.00015	0.00104	CcSEcCtD
Irinotecan—Dizziness—Dexamethasone—ankylosing spondylitis	0.000146	0.00101	CcSEcCtD
Irinotecan—Dizziness—Betamethasone—ankylosing spondylitis	0.000146	0.00101	CcSEcCtD
Irinotecan—Insomnia—Methotrexate—ankylosing spondylitis	0.000145	0.001	CcSEcCtD
Irinotecan—Nausea—Triamcinolone—ankylosing spondylitis	0.000144	0.000997	CcSEcCtD
Irinotecan—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000144	0.000995	CcSEcCtD
Irinotecan—Nausea—Methylprednisolone—ankylosing spondylitis	0.000144	0.000995	CcSEcCtD
Irinotecan—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000143	0.000988	CcSEcCtD
Irinotecan—Somnolence—Methotrexate—ankylosing spondylitis	0.000142	0.000985	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000141	0.000977	CcSEcCtD
Irinotecan—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000141	0.000976	CcSEcCtD
Irinotecan—Vomiting—Dexamethasone—ankylosing spondylitis	0.00014	0.000968	CcSEcCtD
Irinotecan—Vomiting—Betamethasone—ankylosing spondylitis	0.00014	0.000968	CcSEcCtD
Irinotecan—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000139	0.000963	CcSEcCtD
Irinotecan—Rash—Betamethasone—ankylosing spondylitis	0.000139	0.00096	CcSEcCtD
Irinotecan—Rash—Dexamethasone—ankylosing spondylitis	0.000139	0.00096	CcSEcCtD
Irinotecan—Dermatitis—Betamethasone—ankylosing spondylitis	0.000139	0.000959	CcSEcCtD
Irinotecan—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000139	0.000959	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000138	0.000957	CcSEcCtD
Irinotecan—Fatigue—Methotrexate—ankylosing spondylitis	0.000138	0.000955	CcSEcCtD
Irinotecan—Headache—Betamethasone—ankylosing spondylitis	0.000138	0.000954	CcSEcCtD
Irinotecan—Headache—Dexamethasone—ankylosing spondylitis	0.000138	0.000954	CcSEcCtD
Irinotecan—Asthenia—Prednisone—ankylosing spondylitis	0.000138	0.000951	CcSEcCtD
Irinotecan—Pain—Methotrexate—ankylosing spondylitis	0.000137	0.000948	CcSEcCtD
Irinotecan—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000132	0.000913	CcSEcCtD
Irinotecan—Diarrhoea—Prednisone—ankylosing spondylitis	0.000131	0.000907	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000131	0.000906	CcSEcCtD
Irinotecan—Nausea—Dexamethasone—ankylosing spondylitis	0.000131	0.000904	CcSEcCtD
Irinotecan—Nausea—Betamethasone—ankylosing spondylitis	0.000131	0.000904	CcSEcCtD
Irinotecan—Dizziness—Prednisone—ankylosing spondylitis	0.000127	0.000877	CcSEcCtD
Irinotecan—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000127	0.000876	CcSEcCtD
Irinotecan—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000127	0.000876	CcSEcCtD
Irinotecan—Vomiting—Prednisone—ankylosing spondylitis	0.000122	0.000843	CcSEcCtD
Irinotecan—Rash—Prednisone—ankylosing spondylitis	0.000121	0.000836	CcSEcCtD
Irinotecan—Dermatitis—Prednisone—ankylosing spondylitis	0.000121	0.000835	CcSEcCtD
Irinotecan—Headache—Prednisone—ankylosing spondylitis	0.00012	0.000831	CcSEcCtD
Irinotecan—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000118	0.000816	CcSEcCtD
Irinotecan—Asthenia—Methotrexate—ankylosing spondylitis	0.000115	0.000795	CcSEcCtD
Irinotecan—Nausea—Prednisone—ankylosing spondylitis	0.000114	0.000788	CcSEcCtD
Irinotecan—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00011	0.000758	CcSEcCtD
Irinotecan—Dizziness—Methotrexate—ankylosing spondylitis	0.000106	0.000733	CcSEcCtD
Irinotecan—Vomiting—Methotrexate—ankylosing spondylitis	0.000102	0.000705	CcSEcCtD
Irinotecan—Rash—Methotrexate—ankylosing spondylitis	0.000101	0.000699	CcSEcCtD
Irinotecan—Dermatitis—Methotrexate—ankylosing spondylitis	0.000101	0.000698	CcSEcCtD
Irinotecan—Headache—Methotrexate—ankylosing spondylitis	0.0001	0.000694	CcSEcCtD
Irinotecan—Nausea—Methotrexate—ankylosing spondylitis	9.52e-05	0.000658	CcSEcCtD
